Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Antonescu
    Antonescu
  2. Wolden
    Wolden
  3. Modak
    Modak
  4. Cheung
    Cheung
  5. Dunkel
    Dunkel
  6. Kushner
    Kushner
  7. Kramer
    Kramer
  8. Meyers
    Meyers
  9. Wexler
    Wexler
  10. La Quaglia
    La Quaglia

Groups

  1. Pediatrics, Department of (437)
  2. GSK Faculty (256)
  3. Tow Center for Developmental Oncology (TCDO) (242)
  4. Center for Hematologic Malignancies (191)
  5. Survivorship Research (188)
  6. Department of Pathology and Laboratory Medicine (178)
  7. Pediatric Leukemia (150)
  8. Surgery (136)
  9. Neuroblastoma Service (122)
  10. Neuro-Oncology Service (116)
Search Within
Formats
  1. Journal Article (489)
  2. Meeting Abstract (247)
  3. Review (26)
  4. Correspondence (11)
  5. Guidelines (10)
  6. Editorial (5)
  7. Conference Paper (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Pediatrics, Department of (437)
  2. GSK Faculty (256)
  3. Tow Center for Developmental Oncology (TCDO) (242)
  4. Center for Hematologic Malignancies (191)
  5. Survivorship Research (188)
  6. Department of Pathology and Laboratory Medicine (178)

More Groups

People
  1. Cristina Antonescu (108)
  2. Suzanne Wolden (74)
  3. Shakeel Modak (71)
  4. Nai-Kong Cheung (70)
  5. Brian Kushner (66)
  6. Ira Dunkel (66)

More People

Years
  1. 2025 (29)
  2. 2024 (29)
  3. 2023 (60)
  4. 2022 (57)
  5. 2021 (57)
  6. 2020 (56)

More Years

Publications
  1. Pediatric Blood and Cancer (551)
  2. Genes Chromosomes and Cancer (189)
  3. Developmental Dynamics (24)
  4. Wiley Interdisciplinary Reviews: Developmental Biology (7)
  5. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (4)
  6. Echocardiography (3)

More Publications

Results (791)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of intraventricular 131I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Suzanne, W.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Carrasquillo, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Unique staffing model for nurse practitioners at an outpatient pediatric ambulatory care center
    Meeting Abstract

    Glincher, R.; Ruggiero, J.; Shrager, L.; Swanson, K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Pneumatosis intestinalis in the pediatric oncology population: An eleven year retrospective review at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Bailey, K.; Kodikara, H.; Price, A.; Mauguen, A.; LaQuaglia, M.; Boulad, F.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Outpatient step-down management of low-risk pediatric patients with fever and neutropenia
    Meeting Abstract

    Smith, M.; Massey, A.; Kinnaman, M.; Fassel, H.; Camacho-Bydume, C.; Bailey, K.; Seo, S.; Wexler, L.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Neurologic complications from central nervous system neuroblastoma metastases
    Meeting Abstract

    Kramer, K.; Khakoo, Y.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save